Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study
Authors:
Open Access
- 23 May 2017
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 8, 880
Abstract
Candida glabrata is an increasingly important cause of invasive candidiasis. In China, relatively little is known of the molecular epidemiology of C. glabrata and of its antifungal susceptibility patterns. Here we studied 411 non-duplicate C. glabrata isolates from 411 patients at 11 hospitals participating in the National China Hospital Invasive Fungal Surveillance Net program (CHIF-NET; 2010-2014). Genotyping was performed using multilocus sequence typing (MLST) employing six genetic loci and by microsatellite analysis. Antifungal susceptibility testing was performed using Sensititre YeastOne™ YO10 methodology. Of 411 isolates, 35 sequence types (ST) were identified by MLST and 79 different genotypes by microsatellite typing; the latter had higher discriminatory power than MLST in the molecular typing of C. glabrata. Using MLST, ST7 and ST3 were the most common STs (66.4 and 9.5% of all isolates, respectively) with 24 novel STs identified; the most common microsatellite types were T25 (30.4% of all isolates) and T31 (12.4%). Resistance to fluconazole (MIC > 32 μg/mL) was seen in 16.5% (68/411) of isolates whilst MICs of >0.5 μg/mL for voriconazole, >2 μg/mL for itraconazole and >2 μg/mL for posaconazole were seen for 28.7, 6.8, and 7.3% of isolates, respectively; 14.8% of all isolates cross-resistant/non-wide-type to fluconazole and voriconazole. Fluconazole resistant rates increased 3-fold over the 5-year period whilst that of isolates with non-WT MICs to voriconazole, 7-fold. All echinocandins exhibited >99% susceptibility rates against all isolates but notably one isolate exhibited multi-drug resistance to the azoles and echinocandins. The study has provided a global picture of the molecular epidemiology and drug resistance rates of C. glabrata in China during the period of the study.Keywords
This publication has 32 references indexed in Scilit:
- Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of ResistanceFrontiers in Microbiology, 2016
- MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrataMedical Mycology, 2015
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory ConcentrationsClinical Infectious Diseases, 2013
- Candida glabrata strain relatedness by new microsatellite markersEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- National Surveillance of Fungemia in Denmark (2004 to 2009)Journal of Clinical Microbiology, 2011
- Microsatellite analysis and susceptibility to FCZ ofCandida glabratainvasive isolates in Sfax Hospital, TunisiaMedical Mycology, 2011
- The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agentsin vitroExpert Review of Anti-infective Therapy, 2010
- A review of molecular techniques to type Candida glabrata isolatesMycoses, 2009
- Uneven Distribution of Mating Types among Genotypes of Candida glabrata Isolates from Clinical SamplesEukaryotic Cell, 2009
- Multilocus Sequence Typing of Candidaglabrata Reveals Geographically EnrichedCladesJournal of Clinical Microbiology, 2003